As the baseball world eagerly anticipates the start of Spring Training, the Miami Marlins are gearing up for an exciting season, but one burning question remains: Can their pitching rotation rise to the challenge after a lackluster performance last year? Today’s FanFest at LoanDepot Park offered a glimpse into the team’s future, particularly focusing on two key pitchers: Max Meyer and Braxton Garrett. But here’s where it gets intriguing—both are returning from significant injuries, and their roles in 2026 could redefine the Marlins’ rotation.
Max Meyer, the 26-year-old right-hander and 2020 first-round draft pick, shared encouraging updates about his recovery from left hip surgery. In a conversation with reporters, Meyer expressed optimism, stating, ‘Everything feels good, how it should feel.’ This is a significant milestone for the young pitcher, who missed substantial time due to Tommy John surgery in 2023. Despite his limited MLB experience—just 127 2/3 innings with a 5.29 ERA—Meyer’s potential remains high. However, his tendency to allow hard contact and home runs raises questions about his long-term effectiveness as a starter. Manager Clayton McCullough has confirmed Meyer will remain in the rotation, but can he sustain a full workload?
Braxton Garrett, on the other hand, is a more seasoned arm with a proven track record. The 28-year-old lefty, drafted seventh overall in 2016, excelled from 2022-23 with a 3.63 ERA over 247 2/3 innings. Yet, two injury-plagued seasons have left fans wondering if he can reclaim his former glory. Garrett’s ability to induce groundballs and limit walks makes him a valuable asset, but after missing all of 2025 due to elbow surgery, his durability is in question. With Sandy Alcantara and Eury Pérez anchoring the rotation, Garrett’s return to form could be a game-changer—or a risky gamble.
And this is the part most people miss: the Marlins’ first base situation is a wide-open competition. With Eric Wagaman traded to the Twins, the team is exploring unconventional options. Christopher Morel, Griffin Conine, and Liam Hicks are all in the mix, despite limited or no experience at first base. Morel, a former above-average hitter, is willing to give it a shot, while Conine’s versatility makes him an intriguing emergency option. Hicks, the only one with prior first base experience, could split time based on matchups. Is this a bold experiment or a recipe for disaster?
As the Marlins navigate these uncertainties, one thing is clear: 2026 will be a season of high stakes and big questions. Can Meyer and Garrett stay healthy and perform? Will the first base experiment pay off? And most importantly, can the Marlins overcome their rotation woes to contend in a competitive division? What’s your take? Do you think Meyer and Garrett can deliver, or is the Marlins’ pitching staff still a work in progress? Let’s hear your thoughts in the comments!
